Published in J Clin Invest on July 14, 2005
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Regulation of adaptive immunity by the innate immune system. Science (2010) 8.00
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 6.67
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
Macrophage diversity in renal injury and repair. J Clin Invest (2008) 4.41
Toll-like receptors and cancer. Nat Rev Cancer (2008) 4.29
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature (2010) 3.70
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest (2008) 2.82
Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem (2008) 2.53
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis (2013) 2.39
Macrophage activation by endogenous danger signals. J Pathol (2008) 2.38
The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37
The impact of the extracellular matrix on inflammation. Nat Rev Immunol (2010) 2.30
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One (2012) 2.18
Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem (2009) 2.12
Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum (2011) 2.11
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest (2010) 2.07
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol (2015) 1.91
HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol (2010) 1.89
The renal mononuclear phagocytic system. J Am Soc Nephrol (2011) 1.84
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J (2010) 1.82
Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel) (2014) 1.74
Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol (2012) 1.73
The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal (2009) 1.72
Pathway signature and cellular differentiation in clear cell renal cell carcinoma. PLoS One (2010) 1.70
Toll-like receptor 4 in CNS pathologies. J Neurochem (2010) 1.68
Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol (2015) 1.66
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50
Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev (2009) 1.49
Decorin: a guardian from the matrix. Am J Pathol (2012) 1.46
The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep (2009) 1.44
Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol (2009) 1.43
Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med (2010) 1.41
Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol (2011) 1.38
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem (2014) 1.32
TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol (2010) 1.32
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol (2012) 1.30
Immunopathogenesis of osteoarthritis. Clin Immunol (2013) 1.29
The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal (2009) 1.25
Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J (2013) 1.22
The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One (2009) 1.22
Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology (2010) 1.20
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol (2009) 1.20
The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int (2013) 1.18
Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol (2010) 1.14
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
The innate immune system in allograft rejection and tolerance. J Immunol (2007) 1.13
Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem (2009) 1.13
Innate immunity and inflammation in systemic sclerosis. Curr Opin Rheumatol (2009) 1.12
Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem (2012) 1.12
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle (2012) 1.11
Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem (2011) 1.10
Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leukoc Biol (2010) 1.09
The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm (2010) 1.07
Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond) (2011) 1.07
Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer (2012) 1.06
Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken) (2010) 1.06
TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One (2014) 1.05
Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J Immunother (2012) 1.05
Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler Thromb Vasc Biol (2012) 1.04
Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM (2014) 1.04
Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep (2012) 1.04
The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem (2012) 1.04
Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat Rev Rheumatol (2015) 1.03
Toll-like receptors and myocardial inflammation. Int J Inflam (2011) 1.03
Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol (2014) 1.03
Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm (2013) 1.02
Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am J Pathol (2009) 1.02
Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J Biol Chem (2012) 1.02
Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration. Eur Cell Mater (2015) 1.01
Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem (2007) 1.01
Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care (2011) 0.99
Update on the role of Toll-like receptors during bacterial infections and sepsis. Wien Med Wochenschr (2010) 0.98
Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia. Oncotarget (2010) 0.98
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro Oncol (2013) 0.98
Lumican binds ALK5 to promote epithelium wound healing. PLoS One (2013) 0.97
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance. Br J Cancer (2013) 0.97
Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J Biol Chem (2013) 0.97
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol (2015) 0.97
Age-dependent alterations of decorin glycosaminoglycans in human skin. Sci Rep (2013) 0.96
Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol (2009) 0.96
Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage. Am J Pathol (2010) 0.95
Hyaluronan digestion controls DC migration from the skin. J Clin Invest (2014) 0.95
Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. Am J Pathol (2010) 0.94
Links between Toll-like receptor 4 and breast cancer. Oncoimmunology (2013) 0.94
The role for decorin in delayed-type hypersensitivity. J Immunol (2011) 0.94
Role of TLR2-dependent inflammation in metastatic progression. Ann N Y Acad Sci (2011) 0.94
Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol (2014) 0.93
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta (2015) 0.92
The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol (2011) 0.92
Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One (2012) 0.92
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators Inflamm (2016) 0.92
Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol (2014) 0.91
Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum Mol Genet (2014) 0.91
Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens (2009) 0.90
Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions. Respir Res (2014) 0.90
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Innate immune recognition. Annu Rev Immunol (2001) 26.65
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Toll-like receptors in innate immunity. Int Immunol (2005) 12.24
The immunopathogenesis of sepsis. Nature (2002) 11.83
Points of control in inflammation. Nature (2002) 10.61
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4) J Exp Med (1999) 7.62
Inferences, questions and possibilities in Toll-like receptor signalling. Nature (2004) 7.57
Innate immunity. N Engl J Med (2000) 7.03
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem (2001) 4.74
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl (1995) 3.52
Microbial adherence to and invasion through proteoglycans. Infect Immun (1997) 3.22
The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem (1999) 3.08
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84
Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol (2003) 2.82
Vimentin is secreted by activated macrophages. Nat Cell Biol (2003) 2.63
Toll, a new piece in the puzzle of innate immunity. J Exp Med (1999) 2.36
The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol (2003) 2.26
Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol (2003) 2.24
Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J (2002) 2.05
Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med (2001) 1.96
Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology (2002) 1.87
The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol (1999) 1.76
Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol (2002) 1.52
Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood (2000) 1.48
Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J (2001) 1.45
Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol (1994) 1.42
Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest (1993) 1.40
Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J Exp Med (2005) 1.40
Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med (2002) 1.35
Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol (2002) 1.34
TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J Immunol (1994) 1.32
Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J Am Soc Nephrol (2002) 1.23
Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology (2001) 1.20
Carbohydrate-mediated recognition systems in innate immunity. Immunol Rev (2000) 1.19
Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J Cell Sci (2003) 1.19
Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J Cell Biochem (2000) 1.17
Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J (2005) 1.15
Tumour necrosis factor-alpha interacts with biglycan and decorin. FEBS Lett (2002) 1.15
Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells. J Biol Chem (2003) 1.14
The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J Biol Chem (2002) 1.08
Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol (2003) 1.03
Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury. Am J Pathol (2004) 1.03
Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J (2001) 1.00
Transcriptional regulation of the human biglycan gene. J Biol Chem (1996) 1.00
Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med (2000) 0.98
Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem (1992) 0.96
Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int (1998) 0.94
Different usage of the glycosaminoglycan attachment sites of biglycan. J Biol Chem (2001) 0.92
Tumour necrosis factor-alpha interacts with laminin and functions as a pro-adhesive cytokine. Immunology (1995) 0.92
Adenoviral delivery of human and viral IL-10 in murine sepsis. J Immunol (2001) 0.91
Haemopoietic biglycan produced by brain cells stimulates growth of microglial cells. J Neuroimmunol (2000) 0.89
Adenovirus-mediated gene transfer of the proteoglycan biglycan induces fibroblastic responses in the lung. Chest (1997) 0.87
Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva. J Periodontal Res (2005) 0.82
Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med (2009) 6.72
Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80
Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature (2008) 3.05
Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron (2006) 3.04
Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes (2006) 2.85
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J Clin Invest (2013) 2.48
Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell (2005) 2.46
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest (2008) 2.46
Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology (2002) 2.46
Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics (2006) 2.37
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci U S A (2007) 2.24
TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol (2008) 2.23
Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell (2008) 2.21
Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem (2004) 2.14
Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem (2009) 2.12
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice. Nat Med (2008) 2.12
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest (2010) 2.07
L-type calcium channel inhibitor diltiazem prevents aneurysm formation by blood pressure-independent anti-inflammatory effects. Hypertension (2013) 2.05
Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J (2002) 2.05
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01
Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation (2007) 1.98
Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med (2013) 1.98
Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol (2002) 1.96
Endostatin's antiangiogenic signaling network. Mol Cell (2004) 1.95
Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol (2010) 1.93
deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene (2003) 1.92
AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet (2010) 1.89
E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog (2011) 1.89
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem (2005) 1.82
Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80
Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res (2009) 1.80
Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem (2009) 1.79
Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res (2009) 1.74
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J (2004) 1.74
Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol (2005) 1.72
Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int (2004) 1.72
The effect of 3D hydrogel scaffold modulus on osteoblast differentiation and mineralization revealed by combinatorial screening. Biomaterials (2010) 1.71
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest (2002) 1.70
Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol (2005) 1.69
Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol (2011) 1.64
Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res (2005) 1.64
Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res (2005) 1.62
Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int (2009) 1.62
Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J (2004) 1.60
A wild zebra chase. Nephrol Dial Transplant (2007) 1.60
Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. Am J Clin Pathol (2002) 1.59
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res (2003) 1.57
Uremia alters HDL composition and function. J Am Soc Nephrol (2011) 1.55
Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab (2008) 1.55
Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension (2005) 1.54
Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol (2003) 1.54
Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab (2008) 1.54
Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol (2002) 1.52
Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone (2007) 1.52
Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. J Am Soc Nephrol (2007) 1.51
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50
cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy. Transplantation (2004) 1.48
Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis. PLoS Biol (2013) 1.48
A primer on iron therapy. Nephrol Dial Transplant (2007) 1.48
Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther (2006) 1.48
Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci U S A (2005) 1.44
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci U S A (2009) 1.44
Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proc Natl Acad Sci U S A (2006) 1.43
Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol (2004) 1.41
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol (2009) 1.41
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. J Hypertens (2004) 1.39
Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis (2002) 1.38
Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol (2008) 1.38
Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am J Pathol (2009) 1.37
Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol (2006) 1.37
High-accuracy amplification of nanogram total RNA amounts for gene profiling. Genomics (2004) 1.35
G-rich DNA suppresses systemic lupus. J Am Soc Nephrol (2005) 1.35
Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res (2004) 1.29
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res (2002) 1.29
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol (2006) 1.28
E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol Ther (2013) 1.28
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis (2009) 1.27
Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol (2009) 1.27
Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS One (2008) 1.27
Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Signal (2011) 1.27
Animal models of osteoarthritis: lessons learned while seeking the "Holy Grail". Curr Opin Rheumatol (2006) 1.27
Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J Biol Chem (2006) 1.27
Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet (2011) 1.26
The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal (2009) 1.25
Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol (2003) 1.25